
Investor in web3 businesses across crypto infrastructure, DeFi, digital assets and blockchain gaming

Investment firm backing researchers and entrepreneurs commercialising early-stage biomedical technologies

Lancet Capital was founded in 1998 as the first SBIC affiliated with an academic medical centre, created to build value for both investors and the founders and management of early-stage biomedical portfolio companies. The firm invests in researchers, clinicians and entrepreneurs working to commercialise technologies in the biomedical field, and says it offers value-adding human capital to portfolio companies throughout the venture-building process, including access to key resources and expertise. Its focus remains squarely on early-stage biomedical businesses rather than spreading more broadly across healthcare or technology sectors, reflecting its origins as a fund built specifically around an academic medical centre's research and clinical networks rather than a general life-sciences mandate.
Summary written by TrustList from the business's own published information, Sep 2026.
2 images - click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Lancet Capital.
Similar listings buyers compare against this one.

Investor in web3 businesses across crypto infrastructure, DeFi, digital assets and blockchain gaming
Slovenian early-stage fund run by successful founders, investing in startups in Slovenia and abroad

Thesis-led venture fund backing technology-enabled change in traditional industries, starting with commerce

Corporate venture arm backing startups that serve the construction and building trades

Norwegian bank serving personal and corporate customers, with online banking in English

Early-stage B2B venture capital firm backed by experienced enterprise operators who invest alongside it
Everything here links back to the same verified catalogue. Pick your next stop.